Related Experiment Video
Updated: Aug 30, 2025
04:05
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
Published on: May 31, 2024
459
Pyoderma gangrenosum in ulcerative colitis - An exuberant and painful complication.
Margarida Gonçalves1, Ana Rebelo2, Raquel Gonçalves3
1Gastrenterology, Braga Hospital, Portugal.
Revista Espanola De Enfermedades Digestivas
|August 31, 2022
Summary
A woman with ulcerative colitis developed painful skin ulcers on her legs. The lesions showed characteristics of pyoderma gangrenosum, a rare inflammatory skin condition.
Area of Science:
- Dermatology
- Gastroenterology
- Internal Medicine
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis often associated with systemic diseases.
- The association between UC and PG highlights complex immune dysregulation.
Observation:
- A 41-year-old female with a history of UC presented with severe abdominal pain and bloody stools.
- She developed rapidly progressing, painful cutaneous lesions on her lower limbs.
- Physical examination revealed deep, ulcerated, necrotic lesions with marked pathergia, consistent with PG.
Findings:
- The patient's clinical presentation and lesion characteristics were highly suggestive of pyoderma gangrenosum.
- Initial antibiotic treatment was ineffective, indicating a non-infectious etiology.
- The case underscores the importance of recognizing mucocutaneous manifestations in IBD patients.
Implications:
- This case emphasizes the need for a high index of suspicion for PG in UC patients presenting with unexplained ulcerative skin lesions.
- Early diagnosis and appropriate management of PG can prevent further complications and improve patient outcomes.
- Understanding the link between IBD and PG may offer insights into shared inflammatory pathways.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
299
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
299
01:30Inflammatory Bowel Disease II: Crohn's Disease
355
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
355
01:17Chronic Bowel Disorders: Introduction
532
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
532
01:29Drugs for Treatment of Ulcerative Colitis in IBD
229
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
229
01:28Peptic Ulcer Disease II: Pathophysiology
756
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
756
01:30Peptic Ulcer Disease I: Introduction
271
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
271